Sustainable Pharmaceutical Packaging Market to Reach US$ 316.05 B by 2033: Eco-Friendly Solutions, Biodegradable Materials & Smart Packaging Driving Growth

Market Size and Growth

Sustainable Pharmaceutical Packaging Market size reached US$ 91.94 Billion in 2024 and is expected to reach US$ 316.05 Billion by 2033, growing at a CAGR of 12.7% during the forecast period 2025-2033, according to DataM Intelligence report.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/sustainable-pharmaceutical-packaging-market?sb

Key Development and Recent Mergers and acquisitions

United States: Recent Sustainable Pharma Packaging Developments

✅ In November 2025, Plastipak reaffirmed its partnership with Bormioli Pharma (USA), highlighting the use of its PPK Natura carbon-capture PET resin for eco-friendly pharmaceutical bottles.

✅ In October 2025, sustainability leaders at CPHI Frankfurt 2025 were awarded for innovations in recyclable and heat-sealable high-barrier paper packaging for pharma, showcasing a shift away from multi-layer plastics.

✅ In September 2025, at CPHI Frankfurt, several pharma packaging suppliers spotlighted new fiber-based secondary packaging, highlighting reduced carbon footprint and aligned sustainability goals.

✅ In August 2025, ACG announced it would scale up its CelluPod paper-based, compostable blister packs (PVC-free), promoting greener primary packaging options.

✅ In June 2025, Great Point Partners acquired a majority stake in Eutecma, a German firm specializing in modular and reusable cold‐chain packaging solutions for pharmaceutical shipments - accelerating the global expansion of eco‐friendly temperature‐controlled logistics

Japan: Recent Sustainable Pharma Packaging Developments

✅ In October 2025, Kaneka was featured for leading sustainable innovation: its Green PlanetTM biodegradable PHA polymer offers mechanical properties like polyolefins while being compostable.

✅ In September 2025, Mitsui Chemicals, Idemitsu Kosan, and Sumitomo Chemical agreed to merge parts of their plastics businesses, including polyolefin units, to jointly develop more recyclable and bio‐based plastics - fortifying their sustainable materials capacity.

✅ In September 2025, Kaneka's Green PlanetTM polymer, already used in pharma film, won the JSBBA Award for achievement in technological research for its microbial fermentation production process.

✅ In August 2025, Kaneka's biodegradable Green Planet polymer was formally adopted by Shionogi Pharma for PTP (press-through) banding film a first in Japanese pharma packaging.

✅ In July 2025, Kaneka further expanded attention on Green Planet, noting its full biodegradability (soil and seawater) and potential to replace petroleum-based plastics in pharmaceutical packaging.

Key Players:

=> Amcor plc, Berry Global Inc., Gerresheimer AG, WestRock Company, Drug Plastics & Glass Co., Inc., CCL Healthcare, Comar, Bormioli Pharma S.p.A., Origin Pharma Packaging, Ascend Packaging Systems LLC., among others.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=sustainable-pharmaceutical-packaging-market

Key Segments:

By Packaging Type

Primary packaging dominates with 60% share, driven by its direct contact with pharmaceutical products, including vials, syringes, and blisters, ensuring product integrity and patient safety. Secondary packaging accounts for 40%, supported by transport, labeling, and protection requirements for storage and distribution.

By Process

Recyclable packaging leads with 38% share, fueled by increasing regulatory emphasis on sustainability and environmental responsibility. Biodegradable packaging accounts for 32%, supported by rising adoption of eco-friendly alternatives in pharmaceutical and biotech industries. Reusable packaging holds 30%, driven by cost efficiency, circular economy initiatives, and sustainability trends.

By Raw Material

Paper & paperboard dominate with 28% share, primarily used in secondary packaging, cartons, and inserts. Glass holds 25%, driven by vials, ampoules, and injectable packaging for stability and sterility. Bioplastics account for 22%, reflecting demand for sustainable and biodegradable solutions. Metal packaging represents 15%, used in caps, closures, and specialty containers. Other materials make up 10%, catering to hybrid and specialty packaging solutions.

By Product Type

Blisters lead with 20% share, driven by oral solid dose packaging and patient convenience. Labels & accessories account for 15%, supported by regulatory and branding requirements. Caps & closures hold 12%, pre-filled inhalers 10%, vials 10%, pre-filled syringes 8%, ampoules 7%, cartridges 5%, and other products 13%, including specialized packaging for niche pharmaceuticals and biologics.

By End-User

Pharma manufacturing dominates with 50% share, driven by in-house production and packaging of drugs and biologics. Contract packaging accounts for 25%, supported by outsourcing trends in pharmaceutical and biotech industries. Retail pharmacy holds 15%, reflecting secondary packaging and labeling requirements, while institutional pharmacy represents 10%, including hospitals and large healthcare facilities.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/sustainable-pharmaceutical-packaging-market?sb

By Region

North America - 38% Share
North America leads with 38%, driven by advanced pharmaceutical manufacturing infrastructure, strict regulatory requirements, and adoption of sustainable and specialized packaging solutions.

Europe - 28% Share
Europe holds 28%, supported by stringent packaging regulations, high biologics production, and growing adoption of recyclable and biodegradable packaging across Germany, U.K., France, Italy, and Spain.

Asia Pacific - 22% Share
Asia Pacific accounts for 22%, fueled by rising pharmaceutical production in China, India, and Japan, along with increasing investment in modern packaging technologies and sustainability initiatives.

South America - 5% Share
South America holds 5%, supported by growing pharmaceutical manufacturing and contract packaging adoption in Brazil, Argentina, and neighboring countries.

Middle East & Africa - 7% Share
The Middle East & Africa represent 7%, driven by emerging pharmaceutical markets, healthcare expansion, and increasing adoption of modern packaging and labeling solutions.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.